Anticalculus efficacy of an essential oil dentifrice containing 1.3% Pyrophosphate ion

Journal of Clinical Dentistry

Volumn 8, Issue 5, 1997, Pages 138-141

  Kohut, B E ^a   Yu, D ^a   Hovliaras Delozier, C ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL OIL; PYROPHOSPHATE; TOOTHPASTE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GINGIVA; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TOOTH BRUSHING; TOOTH CALCULUS;

ADULT; AGED; DENTAL CALCULUS; DENTAL PLAQUE INDEX; DENTIFRICES; DIPHOSPHATES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OILS, VOLATILE; POTASSIUM COMPOUNDS;

EID: 0030671272     PISSN: 08958831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Petrone M, Lobene RR, Harrison LB, Volpe A, Petrone DM: Clinical comparison of the anticalculus efficacy of three commercially available dentifrices. Clin Prev Dent 13:18-21, 1991.
2. Lu KH, Ruhlman CD, Chung K, Adams A, Bollmer BW: A clinical comparison of anticalculus dentifrices over 4 months of use. J Ind Dent Assoc 67:17-18, 1988.
3. Kohut BE, Rubin H, Baron HJ: The relative clinical effectiveness of three anticalculus dentifrices. Clin Prev Dent 11:13-16, 1989.
4. Fairbrother KJ, Kowolik MJ, Curzon MEJ, Müller I, McKeown S, Hill CW, Hannigan C, Bartizek RD, White DJ: The comparative clinical efficacy of pyrophosphate/triclosan, copolymer/triclosan and zinc citrate/triclosan dentifrices for the reduction of supragingival calculus formation. J Clin Dent 8:62-66, 1997.
5. Schiff TG, Volpe AR, Gaffar A, Affilito J, Mitchell RL: The comparative anticalculus effect of dentifrices containing 1.30% soluble pyrophosphate with and without a copolymer. J Clin Dent 2:48-52, 1990.
6. Singh SM, Petrone ME, Volpe AR, Rustogi KN, Norfleet J: Comparison of the anticalculus effect of two soluble pyrophosphate dentifrices with and without a copolymer. J Clin Dent 2:53-55, 1990.
7. Putt MS, Milleman JL, Kleber CJ, Nelson BJ: Effect of a pyrophosphate/baking soda dentifrice in a human calculus model. J Dent Res 74:209, 1995.
8. Volpe AR, Petrone ME, Davies RM: A review of calculus clinical efficacy studies. J Clin Dent 4:71-81, 1993.
9. White DJ: Tartar control dentifrices: current status and future prospects. In: Clinical and Biological Aspects of Dentifrices, G Embery and G Rølla, Eds., Oxford University Press, Oxford, pp. 277-291, 1992.
10. Stookey GK, Jackson RD, Beiswanger BB, Stookey KR: Clinical efficacy of chemicals for calculus prevention. In: Recent Advances in the Study of Dental Calculus, JM ten Cate, Ed., IRL Press, Oxford, pp. 235-258, 1989.
11. Volpe AR, Manhold JH, Hazen SP: In vivo calculus assessment: Part I: A method and its examiner reproducibility. J Periodontol 36:292-298, 1965.
12. Manhold JH, Volpe AR, Hazen SP: In vivo calculus assessment: Part II. A comparison of scoring techniques. J Periodontol 36:299-304, 1965.
13. Volpe AR, Kupczak LJ, King WJ: In vivo calculus assessment: Part III. Scoring techniques, rate of calculus formation, partial mouth exams vs. full mouth exams and intra-examiner reproducibility. Periodontics 5:184-193, 1967.
14. White DJ, Bowman WD, Nancollas GH: Physical-chemical aspects of dental calculus formation and inhibition: In vitro and in vivo studies. In: Recent Advances in the Study of Dental Calculus, JM ten Cate, Ed., IRL Press, Oxford, pp. 175-188, 1989.
15. White DJ: Processes contributing to the formation of dental calculus. Biofouling 4:209-218, 1991.
16. Fischman SL, Picozzi A: Clinical evaluation of anti-calculus agents, methodology and "placebo effect." Pharmocol Therap Dent 1:16-23, 1970.
17. Mankodi S, Charles C, Bartels L, Ross N: Listerine antiseptic and its relationship to calculus formation. J Dent Res 67:402, 1988.
18. Overholser CD, Meiller TF, DePaola LG, Minah GE, Niehaus C: Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. J Clin Periodontol 17:575-579, 1990.
19. Technical bulletin - Tetrapotassium and Tetrasodium pyrophosphate, FMC Corp., 1995.
20. Yu D: The relationship between solubility and bioavailability of pyrophosphate salts. (Personal communication).
21. Winston AE, Miskewitz RM, Walley DR, Berschied JR: Anticalculus dentifrices. U.S. patent no. 5,180,576. 1993.